Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Convertible Loan Notes update

13 Jun 2017 07:00

RNS Number : 8750H
Kin Group PLC
13 June 2017
 

Kin Group Plc / Epic: KIN / Index: AIM

 

RNS ANNOUNCEMENT: The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

13 June 2017

 

KIN GROUP PLC ('KIN' OR 'THE COMPANY')

 

Convertible Loan Notes update

On 15 May 2017, Kin Group Plc (AIM: KIN), the AIM quoted digital wellness provider for corporate organisations trading as Kin Wellness, announced that it had agreed to issue convertible unsecured loan notes with a term of three years ("Notes"), to raise up to £1.125 million (before expenses) in four tranches, to Belastock Capital L.P., an overseas based institutional investor ("Belastock") to fund its general working capital requirements.

The issue of the Notes was subject to the terms and conditions summarised in the announcement dated 15 May. The first tranche of Notes with a nominal amount of £350,000 and a subscription price of £315,000 ("Tranche 1 Notes") were issued on 15 May 2017 with the remaining three tranches being issued at 60 day intervals thereafter.

One of the conditions attaching to the issue of subsequent Notes, which can be waived by Belastock, is that the closing bid price of the Company's ordinary shares (as reported by Bloomberg) falls below £0.001 (0.1 pence) for any five (5) consecutive trading days on or prior to the relevant issue date. The Company notes that this condition was not met at the close of business last night, 12 June 2017.

Notwithstanding this breach of the condition the Directors are pleased to report that Belastock has confirmed its ongoing support for the Company and that it is the current intention of Belastock to subscribe for the remaining tranches of the Notes as previously outlined. The second tranche of the Notes, which should raise approximately £255,000 (net of expenses), are due to be issued in mid-July.

Further announcements will be made as appropriate.

 

 

**ENDS**

 

For further information visit www.kinwellness.com

 

Contact:

 

Anna Gudmundson / Donald Stewart

 

Kin Group Plc

020 7449 4949

Mark Brady / Neil Baldwin

 

SPARK Advisory Partners Limited (Nominated Advisor)

 

020 3368 3551

Claire Louise Noyce

Hybridan LLP, Broker

020 3764 2341

 

Stephanie Forrest

T/F/D, Public Relations

07917 695755

 

Notes

About Kin Wellness

 

Kin Wellness provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Kin Wellness can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

 

The Company's technological edge allows it to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

 

Shares are admitted to trading on the London Stock Exchange AIM market under ticker KIN.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODOKBDPCBKDOAD
Date   Source Headline
17th Dec 20219:06 amRNSSecond Price Monitoring Extn
17th Dec 20219:00 amRNSPrice Monitoring Extension
17th Dec 20217:01 amRNSTrading Update
17th Dec 20217:00 amRNSTwo-year commercial deal with Azerion
14th Dec 202111:06 amRNSSecond Price Monitoring Extn
14th Dec 202111:00 amRNSPrice Monitoring Extension
13th Dec 202112:05 pmRNSBidstack adds three new titles to its portfolio
13th Dec 202111:06 amRNSSecond Price Monitoring Extn
13th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20212:00 pmRNSBidstack Secures Deal with AAA Game Publisher
9th Dec 20213:22 pmRNSChange of Company Secretary
17th Nov 20217:00 amRNSBidstack expands its portfolio with Dovetail Games
11th Nov 20217:00 amRNSBidstack Serves an Ace with Tennis Clash
8th Nov 20214:35 pmRNSPrice Monitoring Extension
1st Nov 202111:05 amRNSSecond Price Monitoring Extn
1st Nov 202111:00 amRNSPrice Monitoring Extension
25th Oct 20217:00 amRNSBidstack Launches New In-Menu Ad Format
11th Oct 20217:00 amRNSBidstack lands two new titles with Illusion Labs
7th Oct 20212:00 pmRNSBidstack Adds First Interactive Story Game
30th Sep 20217:00 amRNSDirectorate Change
14th Sep 20217:00 amRNSBidstack Scores Third Title From Inlogic
2nd Sep 20217:00 amRNSInterim Results - six months ended 30 June 2021
27th Aug 20218:37 amRNSBidstack land new partnership with Suji Games
26th Aug 20217:00 amRNSMotionlab Interactive partnership
28th Jul 20217:00 amRNSBidstack races ahead with new T-Bull partnership
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:27 pmRNSGrant of Share Options, PDMR Dealing
27th Jul 20212:09 pmRNSTR-1: Notification of major holdings
27th Jul 20217:00 amRNSTR-1: Notification of major holdings
23rd Jul 20211:10 pmRNSReplacement: Admission of Ordinary Shares & TVR
23rd Jul 20218:23 amRNSDirector/PDMR Shareholdings
23rd Jul 20218:13 amRNSNew Director
23rd Jul 20218:05 amRNSAdmission of New Ordinary Shares and TVR
19th Jul 202112:07 pmRNSResults of General Meeting
14th Jul 20217:00 amRNSUpdate on General Meeting and Admission Date
9th Jul 202110:00 amRNSExclusive Partnership with Rebound Capital Games
9th Jul 20217:00 amRNSExclusive Partnership with Nordeus
2nd Jul 20215:54 pmRNSPosting of Circular and Notice of General Meeting
2nd Jul 20211:57 pmRNSInitiation of research coverage
2nd Jul 20219:38 amRNSResults of Fundraise
1st Jul 20215:30 pmRNSProposed New Director
1st Jul 20215:15 pmRNS£10m Fundraise by way of an Accelerated Bookbuild
23rd Jun 20217:00 amRNSExpiry of Block Listing and Total Voting Rights
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:36 pmRNSPrice Monitoring Extension
29th Apr 20216:12 pmRNSReplacement: Board Changes
29th Apr 20217:00 amRNSKatherine Hays joins as Strategic Adviser
22nd Apr 202112:50 pmRNS2021 AGM Results
22nd Apr 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.